Viatris Inc. (VTRS) Social Stream
VIATRIS INC (VTRS) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering VTRS.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
---|---|---|---|---|---|---|
2021-12-09 | 10 | $24 | $15 | $19 | $11.37 | 67.11% |
2022-01-20 | 8 | $24 | $15 | $19 | $11.37 | 67.11% |
2022-02-28 | 8 | $24 | $15 | $18.857 | $11.37 | 65.85% |
2022-03-01 | 8 | $24 | $10 | $15.571 | $11.37 | 36.95% |
2022-03-15 | 8 | $16 | $10 | $13 | $11.37 | 14.34% |
2022-05-09 | 7 | $16 | $10 | $13 | $11.37 | 14.34% |
2022-05-10 | 7 | $16 | $10 | $13 | $11.37 | 14.34% |
2022-06-14 | 8 | $15 | $9 | $11.833 | $11.37 | 4.07% |
2022-08-01 | 7 | $15 | $9 | $11.833 | $11.37 | 4.07% |
2022-08-09 | 8 | $16 | $9 | $12.285 | $11.37 | 8.05% |
2022-09-21 | 8 | $16 | $9 | $12.428 | $11.37 | 9.31% |
2022-10-11 | 8 | $16 | $9 | $12.142 | $11.37 | 6.79% |
2022-10-14 | 8 | $16 | $9 | $11.714 | $11.37 | 3.03% |
2022-10-21 | 9 | $16 | $9 | $11.625 | $11.37 | 2.24% |
2022-11-02 | 10 | $16.001 | $9 | $12.111 | $11.37 | 6.52% |
2022-11-08 | 10 | $16.001 | $9 | $12.111 | $11.37 | 6.52% |
2022-11-11 | 9 | $16.001 | $10 | $12.777 | $11.37 | 12.37% |
2022-11-16 | 9 | $16.001 | $10 | $12.889 | $11.37 | 13.36% |
2023-01-03 | 10 | $16.001 | $10 | $12.889 | $11.37 | 13.36% |
2023-01-17 | 10 | $16.001 | $10 | $13 | $11.37 | 14.34% |
2023-01-27 | 10 | $16.001 | $10 | $13.333 | $11.37 | 17.26% |
2023-02-28 | 10 | $16 | $10 | $13.222 | $11.37 | 16.29% |
2023-03-28 | 10 | $16 | $10 | $13.333 | $11.37 | 17.26% |
2023-04-25 | 9 | $16 | $10 | $13.125 | $11.37 | 15.44% |
2023-06-06 | 8 | $16 | $10 | $13.125 | $11.37 | 15.44% |
2023-08-07 | 7 | $16 | $10 | $13 | $11.37 | 14.34% |
2023-08-08 | 7 | $15 | $10 | $12.5 | $11.37 | 9.94% |
2023-08-21 | 6 | $15 | $10 | $12.5 | $11.37 | 9.94% |
2023-10-23 | 6 | $15 | $9 | $11.666 | $11.37 | 2.6% |
2023-11-13 | 5 | $14 | $9 | $11 | $11.37 | -3.25% |
2023-11-22 | 5 | $14 | $9 | $11.2 | $11.37 | -1.5% |
The Trend in the Analyst Price Target
VTRS's average price target has moved down $2.02 over the prior 38 weeks.
VTRS reports an average of 25.64% for its upside potential over the past 46 weeks.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
---|---|---|---|---|---|---|
2023-01-05 | 10 | 16.001 | 10 | 13.000 | 11.84 | 9.8% |
2023-01-17 | 10 | 16.001 | 10 | 13.000 | 11.84 | 9.8% |
2023-02-28 | 10 | 16.000 | 10 | 13.333 | 11.40 | 16.96% |
2023-07-31 | 7 | 16.000 | 10 | 13.000 | 10.53 | 23.46% |
2023-08-07 | 7 | 16.000 | 10 | 13.000 | 11.00 | 18.18% |
VTRS Broker Recommendations Summary
Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
---|---|---|---|---|---|---|
3.6 | 0 | 0 | 3 | 1 | 1 | 5 |
The Trend in the Broker Recommendations
Over the past 21 months, VTRS's average broker recommendation rating worsened by 1.35.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for VTRS as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, VIATRIS INC's average analyst price target is higher than 602.6% of them.
- In terms of how VIATRIS INC fares relative to stocks in the large market cap category, note that its number of analysts covering the stock is greater than 640.75% of that group.
- VTRS has a greater upside potential (average analyst target price relative to current price) than 791.35% of Pharmaceutical Products stocks.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, VIATRIS INC's variance in analysts' estimates is lower than -1215.1% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to VIATRIS INC are TEVA, BHC, and REGN.
View All Top Stocks by Price Target
Is VTRS a Buy, Hold or Sell? See the POWR Ratings now!